These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18075496)

  • 1. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
    J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
    Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
    Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
    Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
    Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
    Riser BL; Cortes P
    Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
    J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
    Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
    Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
    McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
    Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
    Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
    Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.
    Nadarajah R; Milagres R; Dilauro M; Gutsol A; Xiao F; Zimpelmann J; Kennedy C; Wysocki J; Batlle D; Burns KD
    Kidney Int; 2012 Aug; 82(3):292-303. PubMed ID: 22475818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
    Murphy M; Godson C; Cannon S; Kato S; Mackenzie HS; Martin F; Brady HR
    J Biol Chem; 1999 Feb; 274(9):5830-4. PubMed ID: 10026205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.
    Ren S; Babelova A; Moreth K; Xin C; Eberhardt W; Doller A; Pavenstädt H; Schaefer L; Pfeilschifter J; Huwiler A
    Kidney Int; 2009 Oct; 76(8):857-67. PubMed ID: 19657322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the role of connective tissue growth factor in diabetic nephropathy.
    Schmidt-Ott KM
    Kidney Int; 2008 Feb; 73(4):375-6. PubMed ID: 18235518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
    J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.